98%
921
2 minutes
20
Integrating artificial intelligence into clinical photography offers great potential for monitoring skin conditions such as actinic keratosis (AK) and skin field cancerization. Identifying the extent of AK lesions often requires more than analyzing lesion morphology-it also depends on contextual cues, such as surrounding photodamage. This highlights the need for models that can combine fine-grained local features with a comprehensive global view. To address this challenge, we propose AKTransU-net, a hybrid U-net-based architecture. The model incorporates Transformer blocks to enrich feature representations, which are passed through ConvLSTM modules within the skip connections. This configuration allows the network to maintain semantic coherence and spatial continuity in AK detection. This global awareness is critical when applying the model to whole-image detection via tile-based processing, where continuity across tile boundaries is essential for accurate and reliable lesion segmentation. The effectiveness of AKTransU-net was demonstrated through comparative evaluations with state-of-the-art segmentation models. A proprietary annotated dataset of 569 clinical photographs from 115 patients with actinic keratosis was used to train and evaluate the models. From each photograph, crops of 512 × 512 pixels were extracted using translation lesion boxes that encompassed lesions in different positions and captured different contexts. AKtransU-net exhibited a more robust context awareness and achieved a median Dice score of 65.13%, demonstrating significant progress in whole-image assessments. Transformer-driven context modeling offers a promising approach for robust AK lesion monitoring, supporting its application in real-world clinical settings where accurate, context-aware analysis is crucial for managing skin field cancerization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12293264 | PMC |
http://dx.doi.org/10.3390/diagnostics15141752 | DOI Listing |
Int J Dermatol
July 2025
Department of Dermatology, Venereology and Dermatooncology, Semmelweis University, Budapest, Hungary.
Rep Pract Oncol Radiother
August 2025
Department of Dermatology and Venereology, Poznan University of Medical Sciences, Poznań, Poland.
Currently, photodynamic therapy (PDT) is widely used, mainly in treatment of actinic keratosis (AK), especially grades I and II following the Olsen classification. The main side effects include burning, stinging, and pain during irradiation. Alternative protocols include daylight PDT (dPDT), which uses sunlight instead of artificial light after applying a photosensitizer.
View Article and Find Full Text PDFJ Am Acad Dermatol
September 2025
Department of Pharmacology and Toxicology; Department of Dermatology, Boonshoft School of Medicine at Wright State University, Dayton, Ohio; Department of Dayton V.A. Medical Center, Dayton, Ohio. Electronic address:
Onco Targets Ther
August 2025
Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, 230032, People's Republic of China.
Background: Actinic keratosis (AK), a UV-induced precancerous skin condition potentially progressing to cutaneous squamous cell carcinoma (cSCC) with undefined mechanisms, was analyzed for neutrophil extracellular traps (NETs)-related biomarkers to identify key clinical targets.
Methods: Transcriptomic profiles of AK retrieved from the GEO database were analyzed using the "limma" package to screen differentially expressed genes (DEGs), which were intersected with a curated NETs-related gene set to extract differentially expressed NETs-related genes (DE-NRGs). Functional enrichment analyses via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations identified enriched biological processes and pathways.
Dermatologie (Heidelb)
September 2025
Klinik für Dermatologie und Allergologie, Universitätsklinikum Augsburg Medizincampus Süd, Sauerbruchstr. 6, 86179, Augsburg, Deutschland.
Background: The diagnosis of actinic keratosis (AK), basal cell carcinoma (BCC), and psoriasis may present a challenge in everyday dermatological practice. Clinical and dermoscopic assessments often reach their limits, especially in ambiguous or anatomically difficult-to-access lesions. Biopsies are often impractical, and objective tools for treatment monitoring are lacking.
View Article and Find Full Text PDF